Decheng Capital, an investment firm that focuses on the life sciences and healthcare sectors, is raising $650 million for a new fund, Decheng Capital Global Life Sciences Fund IV, it said in a filing to the US Securities and Exchange Commission (SEC) on Tuesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
